All Exelixis support phone numbers are listed below, including customer service phone number(s), General Info support phone number(s), Investors/ Franchasing support phone number(s), Investors/ Franchasing (Computershare Investor Services) support phone number(s), etc. You can also get Exelixis support via email, social networks, help center, or directly check all the customer service contacts of Exelixis.
| Customer Service number | +1 650 837 7000 |
| [General Info] support phone number | +1 833 306 0552 |
| [Investors/ Franchasing] support phone number | +1 650 837 8194 |
|
[Investors/ Franchasing] support phone number
(Computershare Investor Services) |
+1 800 676 0894 |
|
[Investors/ Franchasing] support phone number
(TDD for Hearing Impaired) |
+1 800 952 9245 |
|
[Investors/ Franchasing] support phone number
(Foreign Shareowners) |
+1 781 575 2879 |
Exelixis Overview
Every Exelixis employee is united in an ambitious cause: to launch innovative medicines that give patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. After operating in the challenging biotech sector for more than 25 years, we have a proven track record of resiliency in the face of adversity. The success of our lead product has provided a solid commercial foundation allowing us to reinvigorate our research efforts, and grow our team in areas such as Drug Discovery, Clinical Development and Commercial.
As we expand our global partnerships and further reinvest in R&D to help us discover the next breakthrough for difficult-to-treat cancers, we’re seeking to add talented, dedicated employees to power our mission.
Cancer is our cause. Make it yours, too.
Please see our Community Guidelines: bit.ly/2XXw9w3
For more information about Exelixis, please visit www.exelixis.com, follow @ExelixisInc on Twitter or like Exelixis, Inc. on Facebook.
| Industry | Biotechnology Research |
| Headquarters | Alameda, California |
| Company size | 501-1,000 employees |
| Website | http://www.exelixis.com |